GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 41 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 246 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 246 | -95.9% | 0.00% | – |
| Q4 2017 | $7,000 | -72.0% | 6,067 | -63.2% | 0.00% | – |
| Q3 2017 | $25,000 | -59.0% | 16,465 | +40.3% | 0.00% | – |
| Q2 2017 | $61,000 | +306.7% | 11,734 | +376.6% | 0.00% | – |
| Q1 2017 | $15,000 | +150.0% | 2,462 | +68.4% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 1,462 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +16.7% | 1,462 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -86.0% | 1,462 | -86.7% | 0.00% | – |
| Q1 2016 | $43,000 | -41.9% | 11,026 | -21.1% | 0.00% | – |
| Q4 2015 | $74,000 | -22.9% | 13,982 | 0.0% | 0.00% | – |
| Q3 2015 | $96,000 | -43.2% | 13,982 | +13.7% | 0.00% | – |
| Q2 2015 | $169,000 | +2012.5% | 12,302 | +1618.2% | 0.00% | – |
| Q1 2015 | $8,000 | +60.0% | 716 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | -75.0% | 716 | -66.4% | 0.00% | – |
| Q3 2014 | $20,000 | -9.1% | 2,129 | +85.1% | 0.00% | – |
| Q2 2014 | $22,000 | – | 1,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,000,000 | $21,250,000 | 1.00% |
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $1,685,000 | 0.92% |
| Vivo Capital, LLC | 8,180,000 | $7,000,000 | 0.90% |
| Ghost Tree Capital, LLC | 3,525,000 | $3,016,000 | 0.89% |
| BVF INC/IL | 5,265,000 | $4,505,000 | 0.44% |
| Birchview Capital, LP | 189,000 | $162,000 | 0.11% |
| Quinn Opportunity Partners LLC | 113,100 | $97,000 | 0.01% |
| Centiva Capital, LP | 72,234 | $62,000 | 0.01% |
| DRW Securities, LLC | 240,000 | $205,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,603,085 | $1,372,000 | 0.01% |